Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
PRICE
Prev Close
6.10
Open
5.10
Day Range5.00 – 5.84
5.00
5.84
52W Range4.91 – 15.09
4.91
15.09
7% of range
50-Day MA
7.63(-25.9%)
200-Day MA
8.79(-35.8%)
VOLUME & SIZE
Avg Volume
2.0M
FUNDAMENTALS
P/E (TTM)
-2.8x
Not profitable
EPS (TTM)
—
Div Yield (TTM)
No dividend
Beta
1.00
Market-like
TECHNICAL
RSI (14)
38
Bearish momentum
SPRY News
About
Buy10 analysts
Target $25.50+351.3%
Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.